Key Points
Z4D.SI stock surges 9.76% to S$0.045 in pre-market trading
Medi Lifestyle Limited operates healthcare, outsourced services, and commodity trading segments
Company reports negative profitability with -80.1% net margin and weak liquidity
Meyka AI rates Z4D.SI with B-grade HOLD recommendation and one-year forecast of S$0.0205
Z4D.SI stock is making waves in pre-market trading on May 1, 2026, climbing 9.76% to reach S$0.045 on the Singapore Exchange (SES). Medi Lifestyle Limited, the healthcare and services company behind the ticker, is attracting significant attention with 7.8 million shares traded so far. This surge marks a notable recovery from recent weakness, with the stock bouncing off its day low of S$0.041. Investors are watching Z4D.SI stock closely as trading volume remains elevated compared to typical daily averages, signaling renewed interest in this diversified healthcare player.
Z4D.SI Stock Price Movement and Trading Activity
Z4D.SI stock opened at S$0.043 and has climbed steadily throughout the pre-market session. The stock reached its day high of S$0.045, representing the 9.76% gain from the previous close of S$0.041. Trading volume stands at 7.8 million shares, which is notably lower than the average daily volume of 12.5 million shares, yet still substantial for early morning activity.
The year-to-date performance tells a compelling story. Z4D.SI stock has surged 246% since the start of 2026, recovering dramatically from its 52-week low of S$0.006. However, the stock remains well below its 52-week high of S$0.084, suggesting room for further movement. The current market capitalization sits at approximately S$7.65 million, reflecting the company’s modest size on the SES.
Market Sentiment and Technical Indicators
Technical analysis reveals mixed signals for Z4D.SI stock. The Relative Strength Index (RSI) sits at 50.27, indicating neutral momentum without clear overbought or oversold conditions. However, the Commodity Channel Index (CCI) shows -142.48, suggesting oversold territory that may have triggered today’s buying interest.
Trading Activity: Volume momentum is building with Money Flow Index (MFI) at 72.71, indicating strong buying pressure. The Average True Range (ATR) of 0.01 reflects low volatility typical of micro-cap stocks. The 50-day moving average stands at S$0.02952, while the 200-day average is S$0.01528, showing the stock trades above both key moving averages. Track Z4D.SI on Meyka for real-time updates on these technical levels.
Liquidation Concerns: The current ratio of 0.52 raises liquidity questions, suggesting the company has limited short-term assets relative to liabilities. This metric warrants careful monitoring by investors considering positions in Z4D.SI stock.
Medi Lifestyle Limited Business Operations and Fundamentals
Medi Lifestyle Limited operates across three main segments: Healthcare, Outsourced Services, and Commodity Trading. The company runs postpartum recovery centers under the NADORA brand and offers alternative medicine services through its Back to Life brand, including chiropractic and physiotherapy services. With 1,560 full-time employees across Malaysia, Singapore, and China, the company maintains a diversified revenue base.
Financially, Z4D.SI stock faces headwinds. The company reported negative earnings per share (EPS) of -S$0.01 and a negative price-to-earnings ratio of -4.5. Net profit margin stands at -80.1%, indicating the company is currently unprofitable. However, the price-to-sales ratio of 4.42 suggests the market values the company’s revenue generation potential despite current losses.
Meyka AI Rating and Price Forecast for Z4D.SI Stock
Meyka AI rates Z4D.SI stock with a grade of B, suggesting a HOLD recommendation based on a comprehensive scoring model. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The overall score of 63.06 reflects moderate attractiveness with balanced risk-reward considerations.
Meyka AI’s forecast model projects Z4D.SI stock reaching S$0.0205 within one year, implying potential downside of approximately 54.4% from current levels. However, longer-term projections show recovery potential, with the five-year forecast at S$0.0490, representing 8.9% upside. These forecasts are model-based projections and not guarantees. The company’s negative profitability metrics and weak balance sheet remain key concerns for investors evaluating Z4D.SI stock.
Final Thoughts
Z4D.SI stock’s 9.76% pre-market surge reflects renewed trading interest in Medi Lifestyle Limited, though fundamental challenges persist. The company’s negative profitability, weak liquidity position, and modest market capitalization present significant risks for investors. While the year-to-date recovery of 246% is impressive, the stock remains highly speculative. Meyka AI’s B-grade rating suggests a cautious HOLD stance, with price forecasts indicating potential volatility ahead. Investors should conduct thorough due diligence before committing capital to Z4D.SI stock, particularly given the company’s operational losses and balance sheet constraints. The elevated trading volume today may reflect short-term speculation rather than fundamental improvement in the business.
FAQs
Z4D.SI is climbing due to oversold technical conditions (CCI at -142.48) and strong buying pressure (Money Flow Index at 72.71). The surge likely reflects short-term speculation rather than fundamental business improvements.
Medi Lifestyle operates three segments: Healthcare (postpartum recovery via NADORA brand), Outsourced Services (recruitment and HR), and Commodity Trading (coffee and palm oil). The company employs 1,560 staff across Malaysia, Singapore, and China.
No. Medi Lifestyle reported negative EPS of -S$0.01 and net profit margin of -80.1%, indicating current unprofitability. This represents a significant concern for long-term Z4D.SI investors.
Meyka AI projects Z4D.SI at S$0.0205 within one year (downside from S$0.045) and S$0.0490 in five years. These model-based projections are not guaranteed outcomes.
Key risks include negative profitability, weak liquidity (current ratio 0.52), modest market cap of S$7.65 million, high micro-cap volatility, and negative working capital of S$2.24 million.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)